Nanowear is an A.I.-based remote diagnostics platform built on FDA-cleared cloth nanotechnology, which captures and transmits 85+ dimensions of clinical-grade biomarker data from basic skin contact. Nanowear’s first of-its-kind platform enables a radical leap forward in telemedicine by empowering physicians with quantified decision-making thereby improving outcomes without the need for physical visits
Nanowear’s flagship product SimpleSENSE, also FDA 510(k)-cleared, captures and transmits medical-grade lung function, lung volume / capacity, heart function and cardiac rhythm, blood pressure, and blood flow effectively replacing the stethoscope, blood pressure cuff, ECG and respiration machines. This all-in-one device is also a digital platform via A.I.-based scoring, which provides deep, accurate, continuous, time synchronous and simultaneous assessment of the heart, lungs and upper vascular system by evaluating 120million+ data points / patient / day.
Nanowear’s unique sensing technology coupled with first-of-its-kind multi-layer deep learning, clustering, autoencoders, and generative adversarial methods continue to enable new discoveries and insights on triage-able risk associated with short and long-term diagnostics, or diurnal physiological changes, patient behavioral changes, and non-compliance to post-surgical prescription, acute illness, chronic disease management and oncology treatment.